☆ 4.7 Letter

Albumin-Does formulation matter?

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Meta-analysis: Efficacy and safety of albumin in the prevention and treatment of complications in patients with cirrhosis

Leire Leache et al.

Summary: This systematic review found that albumin reduces mortality risk in cirrhotic patients with spontaneous bacterial peritonitis (SBP) and hepatic encephalopathy (HE), but does not provide additional benefits in other scenarios such as liver transplants or serious adverse events (SAEs). Long-term administration of albumin may be associated with a lower risk of cirrhosis complications and the need for paracentesis.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Real-world survival outcomes in patients with decompensated cirrhosis receiving long term human albumin infusions

Nicholas Hannah et al.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

Scott W. Biggins et al.

HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Albumin-Does formulation matter?

相关参考文献

Meta-analysis: Efficacy and safety of albumin in the prevention and treatment of complications in patients with cirrhosis

Real-world survival outcomes in patients with decompensated cirrhosis receiving long term human albumin infusions

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

导出引文

分享论文